Skip to content
AnalystLens

METLIFE INC 8-K Report, Shareholder Vote Results (Jun 20, 2025)

Reports
Shareholder Matters
Filing Date
Filed June 20, 2025
Period End
June 17, 2025
In the record · 2016–202610-K1110-Q328-K249

MET filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 249 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Jun ’22Jun ’22
  3. Leadership change8-K · Jun ’24Jun ’24

Summary

Summary of the 8-K filed June 20, 2025. Cited figures are marked; the original filing is the authoritative source.

MetLife, Inc. (MET) has filed an 8-K report detailing the outcomes of its annual meeting of common shareholders held on June 17, 2025.

The key resolutions passed include the election of eleven directors for terms expiring at the 2026 annual meeting, the ratification of Deloitte & Touche LLP as the company's independent auditor for 2025, and an advisory approval of the compensation for Named Executive Officers. All director nominees received a substantial majority of "For" votes, indicating strong shareholder confidence in the current board. The ratification of the auditor and the advisory vote on executive compensation also saw significant shareholder approval, with "For" votes outnumbering "Against" votes by a wide margin in both cases.

These results suggest a stable governance framework and continued shareholder support for the company's leadership and its chosen auditors. The "Broker Non-Votes" noted in the director elections represent shares held by brokers where the beneficial owner did not provide voting instructions.

While these do not count for or against a proposal, their presence is standard in many shareholder meetings and does not appear to have impacted the decisive outcomes for the director elections or other proposals. Investors can view these outcomes as a positive sign of established corporate governance practices at MetLife.

Key Highlights

  1. Eleven Directors were elected at the annual meeting, with terms expiring at the 2026 annual meeting.
  2. Shareholder approval was overwhelmingly in favor of electing all nominated Directors.
  3. Deloitte & Touche LLP was ratified as MetLife's independent auditor for the fiscal year 2025.
  4. The compensation paid to the Company's Named Executive Officers was approved on an advisory (non-binding) basis.
  5. All proposals presented to shareholders received strong support, indicating confidence in management and governance.
  6. A significant number of "Broker Non-Votes" were recorded for director elections and executive compensation, a common occurrence at annual meetings.

Frequently Asked Questions

  1. What were the main outcomes of MetLife's annual shareholder meeting on June 17, 2025?

    The main outcomes were the election of eleven Directors, the ratification of Deloitte & Touche LLP as the independent auditor for 2025, and an advisory approval of compensation for Named Executive Officers.

  2. Did all director nominees receive sufficient votes for election?

    Yes, all eleven director nominees received a substantial majority of "Votes For" compared to "Votes Against," indicating strong shareholder support for their election.

  3. What is the significance of the advisory vote on executive compensation?

    The advisory vote on executive compensation is a non-binding shareholder vote. While not legally binding, a strong "For" vote signals shareholder approval and confidence in the company's compensation practices, whereas a "Against" vote can prompt management to re-evaluate its compensation policies.

  4. What are "Broker Non-Votes" and do they affect the outcome?

    Broker Non-Votes occur when a broker holds shares on behalf of a client but has not received voting instructions. These shares are not counted as either "For" or "Against" a proposal, but they can reduce the total number of votes cast and potentially impact the threshold required for approval if it's based on a percentage of shares present.